Last edition
News about "Hari Kiran Chereddi"
HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities
HRV Pharma invests INR 150 crore to expand peptide and high-potent Active Pharmaceutical Ingredient (API) capabilities, strengthening its position in high-value pharmaceutical segments.
Hari Kiran Chereddi | 08/09/2026 | By News Bureau | 124
Indian Pharma's Turning Point: Can the Generics Giant Become a Global Innovator?
India’s pharma industry, long known as the “pharmacy of the world,” now aims to become an innovation hub. To understand this transition, Pharma Industrial India spoke to experts on moving beyond generics toward becoming an “innovator of the world.”
Hari Kiran Chereddi | 14/04/2026 | By Akanki | 415
Where Will Pharma Investments Head Next?
As India’s pharma sector shifts from a volume-driven generics model to an innovation-led ecosystem, its investment landscape is rapidly transforming. Ambitions to become a global innovation hub are pushing companies to rethink capital allocation, with R&D, manufacturing diversification, and digital transformation emerging as priorities.
Hari Kiran Chereddi | 03/12/2025 | By Akanki | 641
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy